forgemax.FORGED. TESTED. PROVEN.
Androgen 275 275mg/ml 10ml Vial by British Dragon
Mass Building

Androgen 275 275mg/ml 10ml Vial by British Dragon

Androgen 275 by British Dragon is a four-ester testosterone blend formulated at 275mg/ml in a 10ml multi-dose vial, engineered to deliver a sustained androgenic baseline while making structured organ-protection supplementation the central priority of cycle management. Each vial provides continuous androgenic coverage across staggered ester release windows, supporting lean-mass accumulation without compromising cardiovascular, hepatic, or renal health when an appropriate supplement protocol is observed. Batch integrity is secured through reversed-phase HPLC potency verification and LAL endotoxin screening; every unit must satisfy both analytical gates before release.

€28.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Four-ester testosterone cascade sustains androgenic receptor occupancy across rapid, intermediate, and extended release windows within a single 275 mg/ml formulation.
  • Graduated androgenic exposure supports lean-mass accumulation while allowing supplement stack intensity to be matched to each cycle phase.
  • Oil-based intramuscular delivery bypasses hepatic portal circulation, eliminating the direct liver-enzyme elevation associated with 17-alpha-alkylated oral androgens.
  • 10ml multi-dose vial format supports structured 10–14 week cycles without mid-cycle resupply interruption.
  • Batch-specific LAL endotoxin screening eliminates pyrogen-related injection-site inflammation as a confounding variable in organ-protection monitoring.
  • Reversed-phase HPLC potency release testing confirms the 275 mg/ml declaration is analytically substantiated at the finished-product stage.
  • Staggered ester pharmacokinetics reduce injection frequency demands, lowering cumulative injection-site stress compared to short-ester-only protocols.

Key takeaways

  • Prioritise omega-3 and TUDCA supplementation from cycle day one, not midway.
  • Monitor haematocrit and eGFR at baseline and week six without exception.
  • Maintain hydration above three litres daily to manage erythrocytosis-driven renal load.
  • Calibrate aromatase-inhibitor dose using mid-cycle bloodwork, not guesswork.
  • Discard opened vials showing any particulate matter or colour deviation immediately.

What Androgen 275 Delivers — and What Organ Protection Means in Practice

Androgen 275 is a pharmaceutically compounded, oil-based testosterone multi-ester injectable that provides androgenic continuity across a graduated release spectrum, making it the platform against which a structured organ-support supplement plan is built rather than added as an afterthought. The four-ester cascade — covering rapid, intermediate, and extended release windows — keeps serum testosterone elevated long enough that protective co-supplementation must be maintained throughout the entire cycle, not merely at its peak. Sustained androgenic exposure elevates haematocrit, shifts hepatic lipid metabolism, and places incremental load on renal filtration capacity; these are quantifiable physiological changes that a defined supplement strategy directly addresses.

Hepatic and Cardiovascular Organ Support

Injectably administered esterified testosterone bypasses first-pass hepatic metabolism entirely, meaning direct hepatotoxic risk is minimal compared to 17-alpha-alkylated oral compounds. Nevertheless, elevated androgenic exposure modulates hepatic lipase activity and suppresses ApoA-I-dependent HDL synthesis, producing measurable lipid shifts that accumulate over a 10–16 week cycle. N-acetylcysteine (NAC) at 600 mg twice daily supports hepatic glutathione status; omega-3 fatty acids dosed at 3–4 g per day attenuate hepatic lipase upregulation, partially preserving HDL. Compared to single-ester testosterone protocols where androgenic exposure is episodic, the continuous androgenic environment of a multi-ester blend sustains lipase upregulation throughout the entire inter-injection interval, making uninterrupted omega-3 supplementation more critical than in short-ester-only cycles.

Renal and Haematological Considerations

Testosterone stimulates erythropoietin secretion, elevating red cell mass and haematocrit. Haematocrit breaching 52% — the threshold cited in standard TRT monitoring guidelines — signals erythrocytosis risk requiring dose reassessment or phlebotomy. Adequate hydration supports renal plasma flow and glomerular filtration rate, both of which manage the increased filtration demand that accompanies erythrocytosis. Standardised blood-panel monitoring at cycle baseline, week six, and post-cycle captures haematocrit trajectory alongside creatinine and eGFR, providing the dataset needed to calibrate supplementation intensity.

Practical Supplement Stack Structure

A functional organ-protection stack for Androgen 275 comprises five categories: antioxidant hepatic support (NAC or TUDCA at 500 mg/day), cardiovascular lipid management (omega-3, plant sterols), erythrocyte management (hydration, monitored phlebotomy if indicated), blood-pressure support (CoQ10 at 200 mg/day, dietary sodium management), and post-cycle HPG-axis recovery supplements (vitamin D, zinc). British Dragon subjects each Androgen 275 batch to LAL endotoxin testing ensuring pyrogen load remains within pharmacopoeial limits for parenteral preparations — a quality step that eliminates injection-site inflammatory load as an additional organ stressor.

Usage

  1. Confirm baseline bloodwork — haematocrit, total testosterone, LDL, HDL, creatinine, and eGFR — before the first injection. These values define your organ-protection supplement starting intensity.
  2. Warm the vial to hand temperature by holding it for 60 seconds; this reduces oil viscosity for cleaner draws without compromising sterility.
  3. Swab the rubber septum with 70% isopropanol and allow it to dry fully before inserting a fresh draw needle. Use a separate, finer injection needle to minimise tissue trauma.
  4. Inject intramuscularly — gluteus medius, vastus lateralis, or deltoid — using slow, steady plunger pressure over 20–30 seconds to distribute the oil depot and reduce post-injection discomfort.
  5. Begin your organ-protection supplement stack on cycle day one: TUDCA or NAC for hepatic support, omega-3 for lipid management, CoQ10 for cardiovascular endothelial support, and maintain hydration above 3 litres/day throughout.
  6. Schedule a mid-cycle blood panel at week six and a post-cycle panel four weeks after the final injection; use both datasets to determine whether supplement stack intensity requires adjustment before and after PCT.

Warnings

Contraindications: Androgen 275 must not be administered to patients with confirmed or suspected prostate carcinoma, male breast carcinoma, polycythaemia vera, severe hepatic impairment, or untreated obstructive sleep apnoea. Individuals with a documented hypersensitivity to sesame oil, arachis oil, or any other constituent of the formulation are likewise excluded from use. This product is not indicated for women of childbearing potential.

Side Effects: Peripheral aromatase-mediated conversion of testosterone to oestradiol gives rise to gynaecomastia and fluid accumulation, with the degree of each effect broadly proportional to weekly androgen load. Erythrocytosis represents the principal haematological concern; the resultant rise in blood viscosity is clinically significant and necessitates serial haematocrit measurement throughout the cycle. In genetically susceptible individuals, androgenic stimulation may accelerate the progression of androgenetic alopecia and precipitate acne vulgaris.

Monitoring: A comprehensive baseline panel must be obtained prior to commencing the cycle, with repeat panels at the six-week mid-cycle point and again four weeks after the final injection; parameters assessed at each interval should include total testosterone, haematocrit, ALT, AST, creatinine, eGFR, LDL, and HDL. Where haematocrit values reach or exceed 52%, dose reduction or therapeutic phlebotomy must be considered in accordance with established clinical thresholds.

PCT: Because the decanoate ester governs the rate-limiting step of clearance, SERM-based post-cycle therapy should be deferred until adequate washout of this fraction has occurred. Either tamoxifen or clomiphene, administered according to standard recovery protocols, is appropriate for restoring hypothalamic-pituitary-gonadal axis function. Supplementary hepatic and cardiovascular support should be continued throughout the full duration of PCT, given that lipid parameters and hepatic enzyme levels may remain perturbed well beyond the date of the last injection.

Frequently asked questions

Which supplements should I take alongside Androgen 275 to protect my liver during a cycle?
Because injectable testosterone esters bypass first-pass hepatic metabolism, direct liver toxicity risk is low, but lipid-mediated hepatic stress is real. TUDCA at 500 mg/day or NAC at 600 mg twice daily are the evidence-supported choices for hepatic glutathione and bile acid support during a multi-ester testosterone cycle. Adding milk thistle as a secondary antioxidant provides additional polyphenol-based hepatoprotection without meaningful drug interaction risk.
Does a multi-ester testosterone blend like Androgen 275 require kidney support supplements?
Kidney protection is driven primarily by haematocrit management rather than direct nephrotoxicity. Testosterone-driven erythrocytosis increases blood viscosity and elevates renal filtration demand. Maintaining daily hydration above 3 litres, monitoring eGFR and serum creatinine at cycle week six, and avoiding concurrent nephrotoxic compounds are the primary renal-protective strategies. Supplemental cranberry extract has been used anecdotally to support renal tubular health, though clinical evidence in this context remains limited.
What cardiovascular supplements are most important when running a testosterone mix at 275mg/ml?
Omega-3 fatty acids at 3–4 g per day directly counter hepatic lipase upregulation that suppresses HDL during sustained androgenic exposure. CoQ10 at 200 mg per day supports mitochondrial endothelial function and has evidence for modest blood-pressure attenuation. Plant sterols at 1.5–2 g per day modulate LDL absorption. These three form the cardiovascular-protection core; baseline and mid-cycle lipid panels confirm whether the stack is achieving its target effect.
How should I store an opened 10ml vial of Androgen 275 to maintain sterility between injections?
Store an opened vial at room temperature between 15–25°C, away from direct light and heat sources. Refrigeration is not required and can increase oil viscosity, making drawing more difficult. Each draw must use a fresh, sterile needle and syringe; swab the rubber septum with 70% isopropanol before every puncture. Discard the vial if the solution shows particulate matter, colour change, or cloudiness at any point during use.
Can I use an insulin syringe to draw Androgen 275, and what volume corresponds to common weekly doses?
At 275 mg/ml, a standard 1 ml insulin syringe can be used for smaller doses, though a 23–25 gauge, 1–1.5 inch needle on a standard 3 ml syringe is more practical for intramuscular depot delivery. At 275 mg/ml, 0.5 ml delivers 137.5 mg, 1 ml delivers 275 mg, and 1.8 ml delivers 495 mg — covering the 250–500 mg/week range commonly observed in supervised use. Drawing with a larger-bore needle and injecting with a finer one minimises septum-core fragmentation and injection discomfort. (2) angle_used

Manufacturer

British Dragon's aseptic fill process for Androgen 275 operates within a classified cleanroom environment where environmental contamination is controlled through continuous non-viable particulate monitoring and scheduled viable-air sampling against validated action limits. The four-ester API blend is verified at the incoming raw-material stage — each ester fraction reviewed against identity and purity specifications — before the combined blend advances to the oil-based fill stage under Grade A laminar-flow conditions. Finished vials are sealed with tamper-evident closures and held under quarantine until batch-release documentation — incorporating both HPLC potency data and LAL endotoxin test results — is reviewed and signed off; only lots satisfying both analytical criteria are released for distribution.

Product details

BrandBritish Dragon
Active ingredienttestosterone mix
Also known asSustanon, Omnadren, Testosterone-Mischung, Androgen 275, British Dragon Sustanon
Strength275 mg
FormVial
Pack size1 piece
Item numberINJ-TMIX-BRD-275-036

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Sustandrol 250mg/ml 10x1ml Ampoules by Balkan PharmaceuticalsGMP Standard

Sustandrol 250mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

€42.00
Suste-Testosterone 250mg 250mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Suste-Testosterone 250mg 250mg/ml 10ml Vial by Beligas Pharmaceuticals

€39.00
Suste-Testosterone 400mg 400mg/ml 10ml Vial by Beligas PharmaceuticalsVerified Manufacturer

Suste-Testosterone 400mg 400mg/ml 10ml Vial by Beligas Pharmaceuticals

€48.00
Susten-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsTop Seller

Susten-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€42.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00